# GOLD Stage I Chronic Obstructive Pulmonary Disease (COPD)

> **NCT01360788** · — · COMPLETED · sponsor: **Laval University** · enrollment: 53 (actual)

## Conditions studied

- Mild Chronic Obstructive Pulmonary Disease
- Respiratory Symptoms
- Physical Activity

## Interventions

- **DRUG:** Combination ipratropium/salbutamol or placebo (nebulization)

## Key facts

- **NCT ID:** NCT01360788
- **Lead sponsor:** Laval University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** —
- **Final completion:** 2011-02
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2011-05-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01360788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01360788, "GOLD Stage I Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01360788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*